Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Pregnancy

dichlororibofuranosylbenzimidazole has been researched along with Pregnancy in 2 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paronetto, MP1
Bianchi, E1
Geremia, R1
Sette, C1
Venkatesh, VC1
Katzberg, HD1

Other Studies

2 other studies available for dichlororibofuranosylbenzimidazole and Pregnancy

ArticleYear
Dynamic expression of the RNA-binding protein Sam68 during mouse pre-implantation development.
    Gene expression patterns : GEP, 2008, Volume: 8, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Alpha-Amanitin; Animals; Cell Nucleus; Cells, Cultured; Chorio

2008
Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung.
    The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Abortion, Therapeutic; Adult; Base Sequence; Cyclic AMP; Dac

1997